FDA Warning Letter — BBT Biotech Gmbh
The FDA took a Warning Letter action against BBT Biotech Gmbh on May 16, 2016 (Baesweiler, Germany). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.
Action Details
- Facility
- BBT Biotech Gmbh
- Date
- May 16, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Center
- CDER
- Location
- Baesweiler (Germany)